Related Experiment Video
Updated: Nov 16, 2025
05:53
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
10.4K
Association between IL1B -511C/T polymorphism and Behçet's disease: a meta-analysis
Baogang Wang1, Yihang Gao2, Yuying Tan3
1Department of Cardiac surgery, First Hospital, Jilin University, Changchun, China.
The Journal of International Medical Research
|February 24, 2021
Summary
The interleukin-1β gene (IL1B) -511C/T polymorphism does not appear to increase Behçet
Area of Science:
- Genetics
- Immunology
- Rheumatology
Background:
- Behçet's disease (BD) is a complex inflammatory disorder.
- The role of the interleukin-1β (IL1B) gene -511C/T polymorphism in BD risk is debated.
- Previous studies yielded conflicting results regarding this association.
Purpose of the Study:
- To systematically evaluate the association between the IL1B -511C/T polymorphism and Behçet's disease risk.
- To provide a comprehensive meta-analysis of existing research.
Main Methods:
- A systematic literature search was conducted across multiple databases (PubMed, Embase, Cochrane Library, CNKI, CBM).
- Relevant studies investigating the IL1B -511C/T polymorphism and BD were included.
- Meta-analysis was performed using Stata 12.0 to calculate odds ratios (ORs) and 95% confidence intervals (CIs).
Main Results:
- The meta-analysis found no significant association between the IL1B -511C/T polymorphism and BD susceptibility across various genetic models.
- Subgroup analysis, including studies adhering to Hardy-Weinberg equilibrium, also showed no link.
- Specific ORs and CIs were calculated for different comparison models (e.g., C vs T, CC vs TT).
Conclusions:
- The IL1B -511C/T polymorphism is unlikely to be a risk factor for Behçet's disease.
- Further large-scale and well-designed studies are warranted to confirm these findings.
- This meta-analysis consolidates current evidence on the IL1B polymorphism and BD.
Related Concept Videos
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
292
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
292
03:18Non-LTR Retrotransposons
12.6K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
12.6K
01:17Chronic Bowel Disorders: Introduction
633
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
633
01:24T Cell Types and Functions
1.7K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.7K